TimeMon-Sat 9.00 AM - 6.00 PM
DACITABINE INJECTION 50MG

DACITABINE INJECTION 50MG

100 INR/Unit

Product Details:

  • Dosage Form Injection (Lyophilized Powder)
  • Indication Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia
  • Salt Composition Decitabine 50 mg
  • Feature Ready to reconstitute, for intravenous administration only
  • Ingredients Decitabine, Excipients
  • Application
  • Physical Color/Texture White to Off-white Lyophilized Powder
  • Click to view more
X

DACITABINE INJECTION 50MG Price And Quantity

  • 1000 , , Unit
  • 100 INR/Unit

DACITABINE INJECTION 50MG Product Specifications

  • Injection (Lyophilized Powder)
  • Ready to reconstitute, for intravenous administration only
  • White to Off-white Lyophilized Powder
  • Odorless
  • Decitabine, Excipients
  • Decitabine 50 mg
  • Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia
  • AS PER INSTRUCTIONS
  • Approved for use in multiple regions (check local regulatory listings)
  • Dacic Healthcare or equivalent manufacturer
  • Stable in 0.9% sodium chloride or 5% dextrose solutions for up to 3 hours at room temperature after reconstitution
  • Prescription Only (Rx)
  • Reconstitute with 10 ml of sterile water for injection
  • Neutropenia, Anemia, Thrombocytopenia, Nausea
  • For use by qualified healthcare professionals only
  • Single-use vial containing 50 mg Decitabine
  • Monitor blood counts frequently during treatment
  • Intravenous infusion
  • Glass vial in a carton with package insert

DACITABINE INJECTION 50MG Trade Information

  • AHEMDABAD, MUNDRA & MUMBAI
  • Telegraphic Transfer (T/T)
  • 10000 , , Unit Per Month
  • 4 Week
  • Yes
  • Free samples available with shipping and taxes paid by the buyer
  • AS PER REQUIREMENT
  • All India
  • WHO-GMP

Product Description

PRODUCT NAME: DACITABINE INJECTION 50MG

PACKING: FOR SINGLE VIAL

COMPANY: OCEAN PHARMACEUTICAL

USES: DACITABINE INJECTION 50MG is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells).



Ready-to-Use Lyophilized Cancer Therapy

DACITABINE INJECTION 50MG is designed for convenience and reliability in oncological treatment. The lyophilized powder quickly reconstitutes with sterile water for injection, providing a solution that's easy for healthcare professionals to administer. Packaged in a secure glass vial with a detailed insert, each dose is formulated for intravenous infusion, offering precision and effectiveness for patients with certain blood cancers.


Strict Quality and Compatibility Standards

Manufactured in India and exported globally, DACITABINE INJECTION meets rigorous quality benchmarks. Its compatibility with common infusion solutions (0.9% sodium chloride or 5% dextrose) ensures stability for up to three hours post-reconstitution at room temperature. Adhering to established regulatory approvals, each vial is intended solely for licensed practitioners' use, supporting consistent therapeutic outcomes.

FAQ's of DACITABINE INJECTION 50MG:


Q: How should DACITABINE INJECTION 50MG be prepared for administration?

A: Reconstitute the lyophilized powder in the single-use vial with 10 ml of sterile water for injection. Gently swirl until completely dissolved. After reconstitution, the solution should be further diluted in either 0.9% sodium chloride or 5% dextrose before intravenous infusion.

Q: What cancers is DACITABINE INJECTION 50MG commonly used to treat?

A: This injection is indicated for the treatment of myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML) in adult patients as part of a chemotherapy regimen.

Q: When should the reconstituted DACITABINE solution be used?

A: The reconstituted solution is stable for up to 3 hours at room temperature when diluted in 0.9% sodium chloride or 5% dextrose. Administration should occur within this time frame to maintain efficacy and safety.

Q: Where is DACITABINE INJECTION 50MG administered?

A: This product is for intravenous use only and must be administered in a clinical or hospital setting by qualified healthcare professionals who can monitor and manage potential side effects.

Q: What precautions should be taken during DACITABINE treatment?

A: Blood counts should be monitored frequently during therapy due to the risk of neutropenia, anemia, and thrombocytopenia. Ensure that only licensed medical personnel prepare and administer the infusion.

Q: What are the common side effects of DACITABINE INJECTION 50MG?

A: Typical side effects include neutropenia, anemia, thrombocytopenia, and nausea. Patients should be closely monitored for any signs of infection, excessive bleeding, or other adverse reactions.

Q: What are the benefits of choosing DACITABINE INJECTION 50MG for eligible patients?

A: DACITABINE INJECTION offers targeted treatment for various hematologic malignancies, with ready-to-reconstitute, precision dosing designed to improve cancer management and patient outcomes under professional healthcare supervision.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'ANTI CANCER MEDICINES' category



Back to top